Veterinary Medical Board/Multidisciplinary Advisory Committee Update

The California Veterinary Medical Board (VMB) and its Multidisciplinary Advisory Committee (MDC) convened on April 18–20, 2023. CVMA Executive Director Dan Baxter, Director of Regulatory Affairs Dr. Grant Miller, and RVT liaison Nicole Dickerson attended the meetings on behalf of the CVMA.

The following motions were passed during the meetings.

Veterinary Medical Board

The VMB approved a proposed rulemaking package that rewrites the minimum standards pertaining to veterinary premises to include large animal fixed premises and house/ranch call practices. Currently, California regulations only address fixed small animal premises, small animal mobile premises, and small animal vaccination clinics.

The VMB voted to approve the VMB Cannabis Recommendation guidelines mandated by the passage of AB 1885 (Kalra), which became effective January 1, 2023.

The VMB approved a statutory proposal to amend California laws regarding out-of-state RVT reciprocity. This proposal will remove the requirement for all RVT school and degree programs to be approved by the VMB and will instead codify existing regulations pertaining to outof-state RVT licensure in California.

The VMB appointed Dr. Allan Drusys, Dr. Andrew Dibbern, Justin Johnson, and Elle Anzalone to the VMB Wellness Evaluation Committee.

The VMB adopted positions on various California legislative bills, including:

• AB 814 (Lowenthal): Veterinary medicine: animal physical rehabilitation—OPPOSE

• AB 1399 (Friedman/Lowenthal): Veterinary medicine: veterinarianclient-patient relationship: telehealth—OPPOSE

• SB 669 (Cortese): Veterinarians: veterinarian-client-patient relationship—OPPOSE, Unless Amended

• AB 1237 (Petrie-Norris): Student financial aid: California Public Interest Veterinary Debt Relief Program— SUPPORT

The next MDC and VMB meetings are scheduled to take place both online and in Sacramento on July 18–20, 2023.

Introducing your friend in the fight — powerful nutrition designed for dogs with cancer.